FCA Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,800
| Closed | -$200K | – | 165 |
|
|
2022
Q3 | $200K | Hold |
6,800
| – | – | 0.08% | 142 |
|
|
2022
Q2 | $370K | Hold |
6,800
| – | – | 0.15% | 122 |
|
|
2022
Q1 | $370K | Hold |
6,800
| – | – | 0.13% | 129 |
|
|
2021
Q4 | $375K | Hold |
6,800
| – | – | 0.13% | 138 |
|
|
2021
Q3 | $351K | Hold |
6,800
| – | – | 0.11% | 108 |
|
|
2021
Q2 | $338K | Hold |
6,800
| – | – | 0.1% | 143 |
|
|
2021
Q1 | $304K | Hold |
6,800
| – | – | 0.09% | 148 |
|
|
2020
Q4 | $313K | Buy |
+6,800
| New | +$313K | 0.1% | 138 |
|
|
2020
Q3 | – | Sell |
-6,800
| Closed | -$347K | – | 209 |
|
|
2020
Q2 | $347K | Hold |
6,800
| – | – | 0.13% | 113 |
|
|
2020
Q1 | $322K | Hold |
6,800
| – | – | 0.14% | 110 |
|
|
2019
Q4 | $399K | Hold |
6,800
| – | – | 0.14% | 113 |
|
|
2019
Q3 | $363K | Hold |
6,800
| – | – | 0.14% | 111 |
|
|
2019
Q2 | $340K | Buy |
6,800
+1,600
| +31% | +$80K | 0.12% | 115 |
|
|
2019
Q1 | $272K | Hold |
5,200
| – | – | 0.11% | 118 |
|
|
2018
Q4 | $248K | Hold |
5,200
| – | – | 0.11% | 115 |
|
|
2018
Q3 | $261K | Hold |
5,200
| – | – | 0.1% | 127 |
|
|
2018
Q2 | $262K | Hold |
5,200
| – | – | 0.1% | 125 |
|
|
2018
Q1 | $254K | Hold |
5,200
| – | – | 0.1% | 127 |
|
|
2017
Q4 | $231K | Hold |
5,200
| – | – | 0.09% | 139 |
|
|
2017
Q3 | $264K | Hold |
5,200
| – | – | 0.11% | 126 |
|
|
2017
Q2 | $280K | Hold |
5,200
| – | – | 0.12% | 112 |
|
|
2017
Q1 | $274K | Hold |
5,200
| – | – | 0.13% | 112 |
|
|
2016
Q4 | $250K | Buy |
+5,200
| New | +$250K | 0.12% | 118 |
|
|
2016
Q3 | – | Sell |
-5,200
| Closed | -$282K | – | 140 |
|
|
2016
Q2 | $282K | Buy |
5,200
+800
| +18% | +$43.4K | 0.14% | 110 |
|
|
2016
Q1 | $223K | Buy |
+4,400
| New | +$223K | 0.12% | 122 |
|